Nilsine Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Nilsine Partners's ELV Position: Q3 2026 in Review
Nilsine Partners reduced its Elevance Health (ELV) stake by 1.9% in Q3 2026, selling an estimated $7.98K and leaving 1,010 shares worth $393K. The position accounts for 0.03% of the portfolio, ranked #350.
Nilsine Partners first reported a position in ELV in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.23M in Q2 2024. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Nilsine Partners held 1,010 shares of Elevance Health worth $393K as of Q3 2026.
- Nilsine Partners sold 20 Elevance Health shares in Q3 2026, an estimated $7.98K.
- Elevance Health made up 0.03% of Nilsine Partners's portfolio in Q3 2026, its #350 holding.
- Nilsine Partners first reported a position in Elevance Health in Q1 2023 and has held it in 15 quarters since.
- Nilsine Partners's Elevance Health position peaked at $1.23M in Q2 2024.
- 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.